Characterization of two-year progression of risk phenotypes of diabetic retinopathy

被引:0
|
作者
Ribeiro, Maria Luisa [1 ,2 ]
Marques, Ines [1 ,2 ]
Ferreira, Sonia [1 ]
Santos, Ana Rita [1 ,2 ]
Santos, Torcato [1 ]
Cunha-Vaz, Jose G. [1 ,2 ]
机构
[1] AIBILI Assoc Innovat & Biomed Res Light & Image, Coimbra, Portugal
[2] Univ Coimbra, Coimbra Inst Clin & Biomed Res iCBR, Fac Med, Coimbra, Portugal
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
F0230
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Results of the Two-year Screening Interval Initiative within the Irish National Diabetic Retinopathy Screening Programme (Retinascreen)
    Keegan, David
    Kelly, S. R.
    Harmon, J.
    McMahon, S.
    McBride, E.
    Acheson, R.
    O'Toole, L.
    Kavanagh, H.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2023, 33 (01) : 9 - 10
  • [42] Effect of Ocular Perfusion Pressure on Incidence of Diabetic Retinopathy in Type 2 Diabetes: A Two-Year Prospective Study
    Yan, Yayi
    Wu, Xinyan
    Li, Yuntong
    Fan, Yiran
    Li, Lingyi
    Tsui, Ching-Kit
    Liu, Kaiqun
    Huang, Wenyong
    Liang, Xiaoling
    Hu, Andina
    TRANSLATIONAL VISION SCIENCE & TECHNOLOGY, 2024, 13 (10):
  • [43] The Wisconsin epidemiologic study of diabetic retinopathy: XVII - The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes
    Klein, R
    Klein, BEK
    Moss, SE
    Cruickshanks, KJ
    OPHTHALMOLOGY, 1998, 105 (10) : 1801 - 1815
  • [44] Ranibizumab Induces Regression of Diabetic Retinopathy in Most Patients at High Risk of Progression to Proliferative Diabetic Retinopathy
    Wykoff, Charles C.
    Eichenbaum, David A.
    Roth, Daniel B.
    Hill, Lauren
    Fung, Anne E.
    Haskova, Zdenka
    OPHTHALMOLOGY RETINA, 2018, 2 (10): : 997 - 1009
  • [45] Anaemia and the risk of progression from non-proliferative diabetic retinopathy to vision threatening diabetic retinopathy
    Li, Yafeng
    Yu, Yinxi
    VanderBeek, Brian L.
    EYE, 2020, 34 (05) : 934 - 941
  • [46] Anaemia and the risk of progression from non-proliferative diabetic retinopathy to vision threatening diabetic retinopathy
    Yafeng Li
    Yinxi Yu
    Brian L. VanderBeek
    Eye, 2020, 34 : 934 - 941
  • [47] The 6-year incidence and progression of diabetic retinopathy and associated risk factors: The New Jersey 725
    Roy, MS
    Affouf, M
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [48] Ocular and Systemic Risk Markers of Diabetic Retinopathy Progression. A Five-Year Longitudinal Study
    Cunha-Vaz, J.
    Martinho, A.
    Marques, I. P.
    Messias, A. L.
    Santos, T.
    Madeira, M. H.
    Lobo, C.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2020, 30 (1_SUPPL) : 9 - 9
  • [49] Risk of Progression of Type 2 Diabetes Individuals with Non-Proliferative Retinopathy: Characterization of Phenotypes in A 1-Year Follow-Up Study
    Ribeiro, L.
    Coimbra, R.
    Santos, T.
    Madeira, M. H.
    Santos, A. R.
    Lobo, C.
    Cunha-Vaz, J.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2021, 31 (2_SUPPL) : 29 - 29
  • [50] VALIDATION OF A RISK STRATIFICATION ALGORITHM FOR PROGRESSION TO REFERABLE DIABETIC RETINOPATHY
    Aldington, S.
    Stratton, I. M.
    Gazis, T.
    Sivaprasad, S.
    Russell, G.
    Scanlon, P. H.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2015, 25 (03) : E13 - E13